RxDoctor Payments Data

Zachary Schwam, MD

Otology & Neurotology · New York, NYNPI 1871956821

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (51.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Acclarent, Inc at 49.6% of the total. Reporting peaked in 2023 at $9,098 and has fallen 93.1% since, to $625 in 2025.

$14,584in general payments, 2019–2025

Across 71 payments — averaging $205.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Acclarent, Inc$7K
  • Integra Lifesciences Corporation$2K
  • Med-el Corporation$2K
  • Cochlear Americas$1K
  • Stryker$1K
  • Intersect ENT, Inc.$278
  • plus $560 from 6 others

What the payments were for

  • Consulting fees$7,48351%
  • Speaking & faculty fees$1481%
  • Travel & lodging$2,04214%
  • Food & beverage$4,19729%
  • Education$7145%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,584 in reported general payments places this provider in the 85th percentile of 26 otology & neurotology providers in New York.

See all otology & neurotology providers in New York

Medicare billing

Part B allowed, 2024
$86,725
Medicare patients
300
Services billed
1,041

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ofloxacin160$12,700
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth23$2,125
Fluocinolone Acetonide Oil47$1,106
Acetic Acid48$811
Ipratropium Bromide32$555
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav30$160
Meclizine Hcl20$106
Ciprofloxacin Hcl11$84
Fluticasone Propionate11$41
Prednisone11$19

Paid to pharmacies, not to this prescriber.

Other otology & neurotology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →